Back

Heart failure prevalence and incidence in Germany: insights in ambulatory drug therapy and comorbidities

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Novel risk factors and AI-enhanced prognostic strategies in heart failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Dominik Jurczyk

Schleswig-Holstein University Clinic, Lubeck Campus, Luebeck (Germany)

5 More presentations in this session

Presentation thumbnail
Hypochloremia in chronic and acute heart failure scenarios: prevalence and risk factors
Doctor P. Llacer (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Metformin associated lower risk of dementia among heart failure patients: a population-based retrospective cohort study
Miss A. Matsumoto (HK)
Abstract Slides Video
Presentation thumbnail
Deep learning by vision transformer based assessment of image quality in echocardiography improves prediction of heart failure specific outcome
Ms A. Romano Martinez (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Impact of coronavirus disease 19 (COVID-19) pandemic on age differences of heart failure with reduced ejection fraction (HFrEF) admissions and in-hospital outcomes
Doctor A. Ceka (Tirana, AL)
Abstract Slides Video
Presentation thumbnail
Impact of recovery of vital signs after a 6-minute walk test over mortality in right heart failure patients.
Doctor C. Chavez Guzman (Mexico City, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Novel risk factors and AI-enhanced prognostic strategies in heart failure

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Temporal trends in the epidemiology of heart failure during the COVID-19 pandemic years in Germany
thumbnail
Congress Presentation
Factors limiting up-titration only concern a fraction of advanced HFrEF patients and might improve over time
thumbnail
Congress Presentation
Baseline characteristics of patients with HFrEF treated at German Heart Failure Units and in routine clinical practice: first data from the CONNECT study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources